Rituximab for High-Risk, Mature B-Cell Non-Hodgkin’s Lymphoma in ChildrenVéronique Minard‐Colin, Thomas G. Gross, Marta Pillon et al.|New England Journal of Medicine|2020Cited by 308
Inhibition of class I histone deacetylases by romidepsin potently induces Epstein-Barr virus lytic cycle and mediates enhanced cell death with ganciclovirKwai Fung Hui, Aks Chiang|International Journal of Cancer|2015Cited by 93
Combination of proteasome and class I HDAC inhibitors induces apoptosis of NPC cells through an HDAC6-independent ER stress-induced mechanismKwai Fung Hui, Aks Chiang|International Journal of Cancer|2014Cited by 68
Intracellular Iron Chelation by a Novel Compound, C7, Reactivates Epstein–Barr Virus (EBV) Lytic Cycle via the ERK-Autophagy Axis in EBV-Positive Epithelial CancersStephanie Pei Tung Yiu, Aks Chiang|Cancers|2018Cited by 27
Identification of Novel Small Organic Compounds with Diverse Structures for the Induction of Epstein-Barr Virus (EBV) Lytic Cycle in EBV-Positive Epithelial MalignanciesChung King Choi, Aks Chiang|PLoS ONE|2015Cited by 24